{"name":"Ferring Pharmaceuticals","slug":"ferring","ticker":"Private","exchange":"Private","domain":"ferring.com","description":"Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specialising in areas such as reproductive health, maternal health, gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years.","hq":"Saint-Prex, Switzerland","founded":0,"employees":"","ceo":"Per Falk","sector":"Reproductive Medicine / GI / Urology","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private","metrics":{"revenue":2800000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1996-01-01","label":"Acthrel first approved","drug":"Acthrel","drugSlug":"corticorelin-ovine","type":"approval","sentiment":"positive"},{"date":"2008-01-01","label":"Firmagon first approved","drug":"Firmagon","drugSlug":"degarelix","type":"approval","sentiment":"positive"},{"date":"2013-01-01","label":"Menopur first approved","drug":"Menopur","drugSlug":"menotropins","type":"approval","sentiment":"positive"},{"date":"2026-06-02","label":"Lutrepulse Phase 3 readout (Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-07-19","label":"Pentasa Phase 3 readout (Ulcerative Colitis (UC))","drug":"Pentasa","drugSlug":"pentasa","type":"phase3_readout","sentiment":"neutral"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-03-01","label":"Lutrepulse Phase 3 readout (Metastatic Breast Cancer)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-12-18","label":"Endometrin Phase 3 readout (Breast Neoplasms)","drug":"Endometrin","drugSlug":"endometrin","type":"phase3_readout","sentiment":"neutral"},{"date":"2027-12-31","label":"Lutrepulse Phase 3 readout (Prostate Cancer)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2028-05-31","label":"Lutrepulse Phase 3 readout (Prostate Carcinoma)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2029-02-03","label":"Endometrin patent expiry (Method of Use)","drug":"Endometrin","drugSlug":"endometrin","type":"patent_expiry","sentiment":"negative"},{"date":"2029-02-03","label":"Endometrin patent expiry (Formulation)","drug":"Endometrin","drugSlug":"endometrin","type":"patent_expiry","sentiment":"negative"},{"date":"2029-03-30","label":"Lutrepulse Phase 2 readout (Prostate Cancer, Oligometastasis)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-01-21","label":"Endometrin patent expiry (Method of Use)","drug":"Endometrin","drugSlug":"endometrin","type":"patent_expiry","sentiment":"negative"},{"date":"2030-03-29","label":"Lutrepulse Phase 3 readout (Biochemically Recurrent Prostate Cancer)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-12-31","label":"Pentasa Phase 2 readout (Ulcerative Colitis, Fecal Microbiota Transplantation)","drug":"Pentasa","drugSlug":"pentasa","type":"phase3_readout","sentiment":"neutral"},{"date":"2035-12-01","label":"Lutrepulse Phase 2 readout (Prostate Cancer (Adenocarcinoma), Prostate Brachytherapy)","drug":"Lutrepulse","drugSlug":"lutrepulse","type":"phase3_readout","sentiment":"neutral"},{"date":"2030-06-01","label":"Xerava patent cliff ($100M at risk)","drug":"Xerava","type":"patent_expiry","sentiment":"negative"},{"date":"2032-06-01","label":"Eleview patent cliff ($50M at risk)","drug":"Eleview","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":20,"colorKey":"immunology","drugs":[{"name":"Crinone","genericName":"Crinone","slug":"crinone","indication":"Other","status":"marketed"},{"name":"Menopur","genericName":"MENOTROPINS","slug":"menotropins","indication":"Development of multiple follicles and pregnancy in ovulatory women","status":"marketed"},{"name":"Novarel","genericName":"Novarel","slug":"novarel","indication":"Other","status":"discontinued"},{"name":"Acthrel","genericName":"corticorelin ovine","slug":"corticorelin-ovine","indication":"Other","status":"marketed"},{"name":"Antocin Ii","genericName":"ATOSIBAN","slug":"atosiban","indication":"Prevention of Premature Labor","status":"marketed"},{"name":"Choriogonadotropin","genericName":"chorionic gonadotrophin","slug":"chorionic-gonadotrophin","indication":"Controlled ovarian stimulation","status":"marketed"},{"name":"Choriongonadotropin","genericName":"Choriongonadotropin","slug":"choriongonadotropin","indication":"Other","status":"marketed"},{"name":"FE 999326","genericName":"FE 999326","slug":"fe-999326","indication":"Other","status":"phase_3"},{"name":"Glycerine","genericName":"Glycerine","slug":"glycerine","indication":"Constipation","status":"marketed"},{"name":"Lutrepulse","genericName":"Lutrepulse","slug":"lutrepulse","indication":"Other","status":"discontinued"},{"name":"MINIRIN Oral Lyophilisate","genericName":"MINIRIN Oral Lyophilisate","slug":"minirin-oral-lyophilisate","indication":"Other","status":"marketed"},{"name":"Menotrophin","genericName":"Menotrophin","slug":"menotrophin","indication":"Other","status":"marketed"},{"name":"Merotocin","genericName":"Merotocin","slug":"merotocin","indication":"Other","status":"discontinued"},{"name":"Norprolac","genericName":"Norprolac","slug":"norprolac","indication":"Other","status":"phase_2"},{"name":"PICOPREP","genericName":"PICOPREP","slug":"picoprep","indication":"Other","status":"marketed"},{"name":"Pabal","genericName":"CARBETOCIN","slug":"carbetocin","indication":"Atony of uterus","status":"marketed"},{"name":"Pentasa","genericName":"Pentasa","slug":"pentasa","indication":"Other","status":"discontinued"},{"name":"Primary nocturnal enuresis","genericName":"Primary nocturnal enuresis","slug":"primary-nocturnal-enuresis","indication":"Other","status":"marketed"},{"name":"REBYOTA™","genericName":"REBYOTA™","slug":"rebyota","indication":"Other","status":"marketed"},{"name":"Recombinant Human Follitropin Alfa","genericName":"Recombinant Human Follitropin Alfa","slug":"recombinant-human-follitropin-alfa","indication":"Other","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Firmagon","genericName":"degarelix","slug":"degarelix","indication":"Advanced Prostatic Carcinoma","status":"marketed"},{"name":"Endometrin","genericName":"progesterone","slug":"endometrin","indication":"Amenorrhea Secondary to Ovarian Dysfunction","status":"marketed"}]}],"pipeline":[{"name":"Firmagon","genericName":"degarelix","slug":"degarelix","phase":"marketed","mechanism":"Firmagon works by blocking the action of gonadotropin-releasing hormone on the pituitary gland, which reduces testosterone production.","indications":["Advanced Prostatic Carcinoma"],"catalyst":""},{"name":"Crinone","genericName":"Crinone","slug":"crinone","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Menopur","genericName":"MENOTROPINS","slug":"menotropins","phase":"marketed","mechanism":"MENOPUR promotes ovarian follicular growth and maturation, requiring hCG for ovulation.","indications":["Development of multiple follicles and pregnancy in ovulatory women"],"catalyst":""},{"name":"Novarel","genericName":"Novarel","slug":"novarel","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Acthrel","genericName":"corticorelin ovine","slug":"corticorelin-ovine","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"Antocin Ii","genericName":"ATOSIBAN","slug":"atosiban","phase":"marketed","mechanism":"Vasopressin V1a receptor","indications":["Prevention of Premature Labor"],"catalyst":""},{"name":"Choriogonadotropin","genericName":"chorionic gonadotrophin","slug":"chorionic-gonadotrophin","phase":"marketed","mechanism":"","indications":["Controlled ovarian stimulation","Hypogonadotropic hypogonadism","Induction of final follicular maturation and luteinization","Induction of ovulation and pregnancy","Prepubertal cryptorchidism"],"catalyst":""},{"name":"Choriongonadotropin","genericName":"Choriongonadotropin","slug":"choriongonadotropin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Endometrin","genericName":"progesterone","slug":"endometrin","phase":"marketed","mechanism":"Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1","indications":["Amenorrhea Secondary to Ovarian Dysfunction","Atrophic vaginitis","Contraception","Corpus Luteum Insufficiency Syndrome","Dysfunctional uterine bleeding"],"catalyst":""},{"name":"FE 999326","genericName":"FE 999326","slug":"fe-999326","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Glycerine","genericName":"Glycerine","slug":"glycerine","phase":"marketed","mechanism":"Small molecule","indications":["Constipation"],"catalyst":""},{"name":"Lutrepulse","genericName":"Lutrepulse","slug":"lutrepulse","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MINIRIN Oral Lyophilisate","genericName":"MINIRIN Oral Lyophilisate","slug":"minirin-oral-lyophilisate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Menotrophin","genericName":"Menotrophin","slug":"menotrophin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Merotocin","genericName":"Merotocin","slug":"merotocin","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Norprolac","genericName":"Norprolac","slug":"norprolac","phase":"phase_2","mechanism":"Adrenergic receptor alpha-1, Adrenergic receptor alpha-2, Dopamine receptor","indications":[],"catalyst":""},{"name":"PICOPREP","genericName":"PICOPREP","slug":"picoprep","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pabal","genericName":"CARBETOCIN","slug":"carbetocin","phase":"marketed","mechanism":"Oxytocin receptor","indications":["Atony of uterus","Prader-Willi syndrome"],"catalyst":""},{"name":"Pentasa","genericName":"Pentasa","slug":"pentasa","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Primary nocturnal enuresis","genericName":"Primary nocturnal enuresis","slug":"primary-nocturnal-enuresis","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"REBYOTA™","genericName":"REBYOTA™","slug":"rebyota","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Recombinant Human Follitropin Alfa","genericName":"Recombinant Human Follitropin Alfa","slug":"recombinant-human-follitropin-alfa","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2023-09-01","type":"regulatory","headline":"Ferring Pharmaceuticals Receives FDA Approval for Xerava","summary":"The FDA has approved Xerava (eravacycline) for the treatment of complicated intra-abdominal infections.","drugName":"Xerava","sentiment":"positive"},{"date":"2022-02-22","type":"deal","headline":"Ferring Pharmaceuticals Acquires Replens","summary":"Ferring Pharmaceuticals has acquired Replens, a leading brand in the feminine care market.","drugName":"Replens","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQZ0FsXzMzR3IxYVVYUzhhQUZZLXNVRm1kN2Qzek9GSlFuckEwNnBUTzdnWHdJOENaWWpQeFJCWHhoY09RQThBRjc0ZkF6SVZ3czFSeVZWb25VbkdXM3AxRmktSEgxMVJkalJESGxFcDJPd1ZKSElYZ3dDRm5JUFZqZ3dYM0xsWG5ybmVMRUtHcnBKSzlCb2k1eG1WNzNkOVlEcGdnSmZKUQ?oc=5","date":"2025-09-01","type":"deal","source":"bioxconomy.com","summary":"Royalty Pharma acquires Amgen’s lung cancer treatment in $950m deal - bioxconomy.com","headline":"Royalty Pharma acquires Amgen’s lung cancer treatment in $950m deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNQWFsOXMwSlFOWnRpUFNJSzRjaTkzSUJpbEZBU21xVHFXNHI1NVNqOWRCRDBNN0dSVGN3Y1MzSmVNUGVzVTREdjdKbDdxald1Mm1yZlZKaVozaEg1VDREbFFmYVRsbUhwaTBxeWk1dUxkQXp5U2tCXzhJc0VFS2F4N0NoeUxqNUhtRFdEaWhHVDU4RmZIU1lz?oc=5","date":"2025-08-05","type":"pipeline","source":"Yahoo Finance","summary":"Denmark Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, H. Lundbeck, Leo, Orifarm, ALK-Abell, Xellia, Takeda, Sandoz, Ferring Pharmaceuticals, FUJIFILM - Y","headline":"Denmark Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, H. Lundbeck, Leo, O","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPUFUyemlCY0F6SkxtT2lEXzk2VUNCLTVkWUlMaE13Q2RkTWFzVDc4UjU1QWdjMmlNbnRvaGtvcTB3OFJUYk1lZmVuSHpJV0dIWFItaHg0aHl4NklIRURJcDhkNnZ3N0poaEo2WWprUi1wSUVuNVBEbFJneHpKdlpVbE5FN2l4bUFwd1RZN0JPd0YtTjJr?oc=5","date":"2025-03-31","type":"pipeline","source":"Medical Marketing and Media","summary":"A miniature horse farmer stars in Ferring’s bladder cancer ad campaign - Medical Marketing and Media","headline":"A miniature horse farmer stars in Ferring’s bladder cancer ad campaign","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNUmlnd3ByVFFrZUlybnhSSmxEaXgwU2FMeVlfbHFwT1o1ZjBUWkZPX21NVGJpdlhMY2VVdVZCSmYzT0RyTVlVeHFLekhxdlFGbnV5V04yUG5LT2dYTVJPcnlBSGdDcXdOTjNXREZQWTVDWHNzWFNsWVJGZjFIRDFRa2RxZGlmZEt1VS1aRHZnUER4cTFVa1pVdE1oT2JBVkZMQzhyOFBxZFJkWU5H0gGyAUFVX3lxTFB1Y2N5NWw4QXhBX0tKY0FuRlJPODVSX3RKSnhUcXI3b19iRmx4Ym02VmZnUkR1dkUzVXlFNTFDYzlmS1g0U202OThtT3QxOUI4d2l3bjhxSnJzYXRtblpRZDNfZUdtNTIyQVJCeXVUcVRUb1RtbE5nRDBqbTRrbW04WHZFTEctZWdyRDdqSnNlWEk0UklsMnQ4YnlMeTc4WlEzMkhIbVowTXY5UWI3RmV6ZkE?oc=5","date":"2024-11-22","type":"deal","source":"Express Pharma","summary":"Genpact extends partnership with Ferring Pharmaceuticals to enhance operations - Express Pharma","headline":"Genpact extends partnership with Ferring Pharmaceuticals to enhance operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOWU9BOGJBZE1Na1NQSXFuWl9Bd0JCRXJuV1djOTlrbzZzM2hpanU2VTRyQnRXZmNYVHI0NWxCNElGUmJoQ1gzUFFrelhCQndBZk1PSkk2X182cUtKN1FZeWhxUkNBakhlcmI1bkUzZHMwMGo3VkRXZFlRRjRpWVpjTEh0OW9iZzVKQWd5YktvYUxEZHlKWTAydGZCeDZLUQ?oc=5","date":"2024-02-22","type":"pipeline","source":"Pharma Voice","summary":"Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health - Pharma Voice","headline":"Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPS0oxVno3Q2xlX1RMZjdqdEVUYzZyMGlJMHFTVVdyck1CLVc3ampqcVMzRGdVZXBnM1BJdUtBX0hjdm1nYkExeWVJLUs5c3N1U2tPZUF0eVdTMC14T205eC1wdTNndWZDSTVtMHNJTkJnQVY5QThrLUw5WlF3VkttSkNSaTc1X2RTeHJpYkZpWGVfdmxlcnZoOGdHZDJzWmZPbWRERGdxSzRqN3V0M2d3?oc=5","date":"2023-12-07","type":"pipeline","source":"Powder & Bulk Solids","summary":"Ferring Pharmaceuticals Announces 50+ Layoffs - Powder & Bulk Solids","headline":"Ferring Pharmaceuticals Announces 50+ Layoffs - Powder & Bulk Solids","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOd2hlRXNnVE8zeEZMdkNsUEtuSWg5anBoUXQxRmZHdndheGF1QmRXa0N5NGFnSGpmLUNuMDdEOUFQamhwemNsUDBIdHNoS2VBRjRQWHBKd3k5VjRVZ0ZGNV92TzZhOEV6OHBQM1VDb0VSWTZPTVJZTzA5QkVhazBxem9mMkJJenl6R2c?oc=5","date":"2023-09-05","type":"trial","source":"Oncology Pipeline","summary":"Royalty Pharma comes to Adstiladrin’s rescue | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Royalty Pharma comes to Adstiladrin’s rescue | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOOUk4XzhmQUpkOXI3T01VakxHWTVUQkhjeDRaSC1jb2VnNWs1Q3RhMXNCQmZST2ZycGVmOWtwVXFjZDdiTjFJdVlYVEFINHdxYS1BclBNRlk4T0dZM0lzTjl0WGhLMGQ4b2JIeXpueDdXQ2JOSno5WEpmeWptRVozVV9vX1J1QlVqRUJTYmltbjNuS3BZN0t3dmFfNA?oc=5","date":"2023-08-24","type":"deal","source":"BioPharma Dive","summary":"Royalty Pharma buys into Ferring’s cancer treatment in first gene therapy deal - BioPharma Dive","headline":"Royalty Pharma buys into Ferring’s cancer treatment in first gene therapy deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQMUtrTGcxZG0yNDlPdmU3RV9EUTVLaEJqWTM4YmVqaVpHODZBZGRJbGNpaU1QanE4VVF4ZVNFTVp6d3Zack5oa0U1LWIxRVF0TXVIemc0Z0dabV9XY2d4aGl6WlFIYmUwazJkbjJxdHJPSVdSa0RuQUJPRV9LcEI2amlJeXFfblFfbTdQRXBMS3pjdDZmYlFVSDc1OGlyQU5NX0VQMGF0a1lFUzFRdXk5T2RXOGljM21ERmwwVkh4aHVPdFJUd1RqUWljTk1XQ1FITXRaenVxb2xURnlNMlRteDJFelVEZ2Q5bEEzN28tTXlBWktsaHY1RF9R0gGAAkFVX3lxTE02RGc2NkZxVHZPQmtCM2tKRHJJQkxqY0xUZFlCMFJITWhmd3ppeU15cVBSVUctcktTdEkycWRoMldIQklsVE1XZXB0cXN6aGp0RGJqTndOYjBOTTgyb2tDN0REZ29HbVczd2VLanhoT1I3dDB3UHM1Q0JkeU5UZjk4MDVzLUM4Tk5pOGZnT2N1NkE3dUFwYW1ZellZbFhjRlhoendkbTV5QUZiVzNpMUhibjEwNmhDTkkzb2VxcDA0WG9jM1VpOHhYS01TckpTNi1aVTBSOWpIeGJXdlh5SnVnWEd5bGJoV2tpQ052cUZ0U2U5c0Z5emRTY2s2R0NzbjU?oc=5","date":"2023-05-06","type":"pipeline","source":"Indian Pharma Post","summary":"CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India - Indian Pharma Post","headline":"CORONA Remedies collaborates with Ferring Pharmaceuticals to commercialize maternal health & urology products in India","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNLThFSWtlVy1HekY4cEhGZnFCTVFCR1J2c0pvZTd0Q2tMTUxHVGd5YnZtc180a0RBUV85UkFBWFU1T1FoUTd5cERzR0hSR242azJHTkxaclQ5SlZmRW5nSDdqVzFuZkdUSlBrTWFKRV9xYVVmZ1FabFFRUkJPN2IzYm5lRnV2YVZjRml0aWEwSlJEdkhFY3pPaUVR?oc=5","date":"2019-11-26","type":"pipeline","source":"PMLiVE","summary":"Private equity firm backs Ferring gene therapy venture - PMLiVE","headline":"Private equity firm backs Ferring gene therapy venture","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPTE4zRzQ3RFBwdG5tOTBydUczN01tU2dvSldBNERMQnNUQ081dlV0c3JpeEUtR0N2OGpTSmV4dDRSbmlaOF9TWHRsbmZveEM1SHNzWFE5SGNpLWg5aTBYR2l0TThFQmxxQmFUUVlodG0xM3c3bEZUSDRNd1JSR0hILUpGdUlhOTFCaVpkRE5xZkdDdFhYZWhHMmphdmE2NGkyTzZFQ0RtcGw?oc=5","date":"2018-04-05","type":"pipeline","source":"Pharmaceutical Technology","summary":"Ferring Pharmaceuticals Biotechnology Centre, Saint-Prex, Switzerland - Pharmaceutical Technology","headline":"Ferring Pharmaceuticals Biotechnology Centre, Saint-Prex, Switzerland","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbWpuNWZ2Rno0Tllkd2kxOTFVLUowYzFVY0I3QnlqaDdtcmxWZ0VWT2tNQktOQUE2T1lqWlNEYXJUUkpiVDd5blBzRVEzSVJZUlZrVXlpc3IzUThKS3IzYTZqaXRjZVhmRFRsZkNiRXpzb3lSWjA3QnpnR3UxSkFLcERORUpqSER2cXhET2hjUy1VaS0zY29wa1o4RzF4SGd0YXhnb2RNLVZzMGFJUVpNbGswcjVEdw?oc=5","date":"2014-10-20","type":"pipeline","source":"Forbes","summary":"Pharma Billionaire Frederik Paulsen Has Serious Exploration Creds - Forbes","headline":"Pharma Billionaire Frederik Paulsen Has Serious Exploration Creds","sentiment":"neutral"}],"patents":[{"drugName":"Endometrin","drugSlug":"endometrin","patentNumber":"10548904","type":"Method of Use","expiryDate":"2029-02-03","territory":"US","genericFilings":[]},{"drugName":"Endometrin","drugSlug":"endometrin","patentNumber":"10537584","type":"Formulation","expiryDate":"2029-02-03","territory":"US","genericFilings":[]},{"drugName":"Endometrin","drugSlug":"endometrin","patentNumber":"8580293","type":"Method of Use","expiryDate":"2030-01-21","territory":"US","genericFilings":[]},{"drugName":"Xerava","drugSlug":"eravacycline","patentNumber":"","type":"Patent Cliff","expiryDate":"2030-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Eleview","drugSlug":"eletriptan","patentNumber":"","type":"Patent Cliff","expiryDate":"2032-06-01","territory":"US","annualRevenue":50000000}],"drugCount":22,"phaseCounts":{"marketed":15,"discontinued":4,"phase_3":2,"phase_2":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Merck & Co.","Pfizer Inc.","Allergan plc"],"therapeuticFocus":["Reproductive Medicine","Gastroenterology","Urology"],"financials":null,"yahoo":null}